semaglutide and exercise & Semaglutide and Exercise | MVP
Description
It reliably increases nausea, vomiting, and diarrhea

In order to maximize the results obtained using GLP-1 RAs in NASH, other combination therapies have also been hypothesized and tested

This could translate into eating better, maintaining a consistent exercise routine, or simply moving more throughout the day

Monotherapy In the LEAD-3 trial, both doses of liraglutide as monotherapy demonstrated significant improvements in glycemic control in comparison with glimepiride ( Table 19 - 5 )

Cross-reactivity, the phenomenon where a test antibody binds to an unintended molecule, requires structural similarity between the intended target and the unintended compound

others describe no change in trajectory
